Surgical management of primary liver cancers during the COVID-19 pandemic

• Verfasst von: Ramouz, Ali [VerfasserIn]
• Verfasst von: Fakour, Sanam [VerfasserIn]
• Verfasst von: Jafari, Marzieh [VerfasserIn]
• Verfasst von: Khajeh, Elias [VerfasserIn]
• Verfasst von: Golriz, Mohammad [VerfasserIn]
• Verfasst von: Majlesara, Ali [VerfasserIn]
• Verfasst von: Merle, Uta [VerfasserIn]
• Verfasst von: Springfeld, Christoph [VerfasserIn]
• Verfasst von: Longerich, Thomas [VerfasserIn]
• Verfasst von: Mieth, Markus [VerfasserIn]
• Verfasst von: Mehrabi, Arianeb [VerfasserIn]
• Titel: Surgical management of primary liver cancers during the COVID-19 pandemic
• Titelzusatz: overcoming the dilemma with standardization
• Verf.angabe: Ali Ramouz, Sanam Fakour, Marzieh Jafari, Elias Khajeh, Mohammad Golriz, Ali Majlesara, Uta Merle, Christoph Springfeld, Thomas Longerich, Markus Mieth, Arianeb Mehrabi
• Jahr: 2023
• Umfang: 8 S.
• Fussnoten: Gesehen am 30.10.2023
• Titel Quelle: Enthalten in: HPB
• Ort Quelle: [London] : Elsevier, 1999
• Jahr Quelle: 2023
• Band/Heft Quelle: 25(2023), 8, Seite 907-914
• ISSN Quelle: 1477-2574
• DOI: doi:10.1016/j.hpb.2023.04.007
• Datenträger: Online-Ressource
• Sprache: eng
• K10plus-PPN: 1868824020

Abstract

Background - The present study evaluates the impact of the pandemic on outcomes after surgical treatment for primary liver cancer in a high-volume hepatopancreatobiliary surgery center. - Methods - Patients, who underwent liver resection for primary liver resection between January 2019 and February 2020, comprised pre-pandemic control group. The pandemic period was divided into two timeframes: early pandemic (March 2020-January 2021) and late pandemic (February 2021-December 2021). Liver resections during 2022 were considered as the post-pandemic period. Peri-, and postoperative patient data were gathered from a prospectively maintained database. - Results - Two-hundred-eighty-one patients underwent liver resection for primary liver cancer. The number of procedures decreased by 37.1% during early phase of pandemic, but then increased by 66.7% during late phase, which was comparable to post-pandemic phase. Postoperative outcomes were similar between four phases. The duration of hospital stay was longer during the late phase, but not significantly different compared to other groups. - Conclusion - Despite an initial reduction in number of surgeries, COVID-19 pandemic had no negative effect on outcomes of surgical treatment for primary liver cancer. The structured standard operating protocol in a high-volume and highly specialized surgical center can withstand negative effects, a pandemic may have on treatment of patients.